Trials / Completed
CompletedNCT04570735
MRI Biomarkers in Diabetic Kidney Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
Diabetic kidney disease is one of the most severe and frequent complications of diabetes. Few preclinical markers are available apart from plasma creatinine and microalbuminuria. These markers are imperfect (some patients with advanced renal disease do not have an increase in markers) and late. Therefor there is an uncovered need to identify complementary biomarkers. Magnetic Resonance Spectroscopy (MRS) is a Magnetic Resonance Imaging (MRI) technique that allows the physiology and biochemistry of human body tissues to be studied in a non-invasive and non-irradiating manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MRI | MRI |
Timeline
- Start date
- 2020-10-07
- Primary completion
- 2024-01-26
- Completion
- 2024-01-26
- First posted
- 2020-09-30
- Last updated
- 2024-12-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04570735. Inclusion in this directory is not an endorsement.